Double-Blind, Multicenter Phase 3 Study Comparing the Efficacy and Safety of OMS103HP With Vehicle in Patients Undergoing Allograft ACL Reconstruction.

Trial Profile

Double-Blind, Multicenter Phase 3 Study Comparing the Efficacy and Safety of OMS103HP With Vehicle in Patients Undergoing Allograft ACL Reconstruction.

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Oct 2012

At a glance

  • Drugs Amitriptyline/oxymetazoline/ketoprofen (Primary)
  • Indications Postoperative pain
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 31 Mar 2011 Primary endpoint 'Clinical-improvement-rate' has not been met according to information reported in an Omeros Corporation media release.
    • 25 Mar 2011 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov.
    • 22 Nov 2010 Planned End Date changed from 1 Aug 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top